Zacks Small Cap Analysis – PBSV Choices Paying Off – Model Slux
By Brad Sorensen, CFA OTC:PBSV READ THE FULL PBSV RESEARCH REPORT Pharma-Bio Serv (OTC:PBSV) introduced outcomes for the quarter ended April 30, 2025. The investments and selections the corporate revamped the previous yr that precipitated PBSV to take a step are displaying the advantages we anticipated to start to see. PBSV returned to profitability within … Read more